Udover ovennævnte er følgende uønskede hændelser rapporteret meget sjældent ved postmarketing erfaring med pravastatin:
Very rare: jaundice, hepatitis, fulminant hepatic necrosis Musculoskeletal and connective tissue disorders Very rare: rhabdomyolysis, which can be associated with acute renal failure secondary to myoglobinuria, myopathy (see section 4.4) Isolated cases of tendon disorders, sometime complicated by rupture